MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 16, Issue 2, 2003, Pages 57-63

  Almeida, Osvaldo P ^a   Burton, Emma J ^b   McKeith, Ian ^b   Gholkar, Anil ^c   Burn, David ^b   O'Brien, John T ^b,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Caudate volume; Parkinson's disease

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN SIZE; CAUDATE NUCLEUS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VOLUMETRY;

AGED; ALZHEIMER DISEASE; CAUDATE NUCLEUS; DEMENTIA; FEMALE; HUMANS; LEWY BODIES; MAGNETIC RESONANCE IMAGING; MALE; PARKINSON DISEASE;

EID: 0038314384     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070676     Document Type: Article

References (33)

1. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P: Risk of dementia in Parkinson's disease: A community-based, prospective study. Neurology 2001;56:730-736.
2. Abdullaev YG, Bechtereva NP, Melnichuk KV: Neuronal activity of human caudate nucleus and prefrontal cortex in cognitive tasks. Behav Brain Res 1998;97:159-177.
3. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA: Cornell scale for depression in dementia. Biol Psychiatry 1988;23:271-284.
4. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW: Parkinson disease neuropathology: Later-developing dementia and loss of the levodopa response. Arch Neurol 2002;59:102-112.
5. Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT: MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia. Neurology 2000;54:1304-1309.
6. Barber R, McKeith I, Ballard C, O'Brien J: Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. J Neurol Neurosurg Psychiatry 2002;72:406-407.
7. Brück A, Portin R, Lindell A, Laihinen A, Bergman J, Haaparanta M, Solin O, Rinne JO: Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 2001;311:81-84.
8. Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, Currie J, Soo M, Olivieri G, Broe GA, Morris JG: Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 2002;125:789-800.
9. Dagher A, Owen AM, Boecker H, Brooks DJ: The role of the striatum and hippocampus in planning: A PET activation study in Parkinson's disease. Brain 2001;124:1020-1032.
10. Deweer B, Lehericy S, Pillon B, Baulac M, Chiras J, Marsault C, Agid Y, Dubois B: Memory disorders in probable Alzheimer's disease: The role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry 1995;58:590-597.
11. Fahn S, Elton RL, and the members of the UPDRS Develoment Committee: The Unified Parkinson's Disease Rating Scale; Fahn S, Marsden CD, Calne DB, Goldstein M (eds): Recent Developments in Parkinson's Disease. Florham Park, Macmillan Healthcare Information, 1987, vol 2, pp 153-163, 293-304.
12. Freeborough PA, Fox NC, Kitney RI: Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 1997;53:15-25.
13. Gibb WR, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51:745-752.
14. 18F]fluoro-L-dopa PET study. Brain 2002;125:1358-1365.
15. Kurosinski P, Guggisberg M, Gotz J: Alzheimer's and Parkinson's disease - Overlapping or synergistic pathologies? Trends Mol Med 2002;8:3-5.
16. Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, Nee LE, O'Connell B, Pollen DA, St George-Hyslop P, Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VM, Iwatsubo T, Trojanowski JQ: Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998;153:1365-1370.
17. Lisanby SH, McDonald WM, Massey EW, Doraiswamy PM, Rozear M, Boyko OB, Krishnan KR, Nemeroff C: Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. J Neural Transm 1993;40(suppl):13-21.
18. Mendez MF, Adams NL, Lewandowski KS: Neuro-behavioral changes associated with caudate lesions. Neurology 1989;39:349-354.
19. Monchi O, Petrides M, Petre V, Worsley K, Dagher A: Wisconsin Card Sorting revisited: Distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 2001;21:7733-7741.
20. O'Brien JT: Is hippocampal atrophy on magnetic resonance imaging a marker for Alzheimer's disease. Int J Geriatr Psychiatry 1995;10:431-435.
21. Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP, Lange KW, Robbins TW: Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992; 115:1727-1751.
22. Parashos IA, Tupler LA, Blitchington T, Krishnan KRR: Magnetic-resonance morphometry in patients with major depression. Psychiatry Res 1998;84:7-15.
23. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK: Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution. Brain 1999;122:1449-1468.
24. Prensa L, Cossette M, Parent A: Dopaminergic innervation of human basal ganglia. J Chem Neuroanat 2000;20:207-213.
25. Reynolds GP, Pearson SJ, Heathfield KW. Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not cerebral cortex. Neurosci Lett 1990;113:95-100.
26. Rombouts SA, Barkhof F, Witter MP, Scheltens P: Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000;285:231-233.
27. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard D: CAMDEX: A standardised instrument for the diagnosis of dementia in the elderly. Brit J Psych 1986;149:698-709.
28. Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, Voigt K, Dichgans J, Klockgether T: Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999;45:65-74.
29. Starkstein SE, Brandt J, Folstein S, Strauss M, Berthier ML, Pearlson GD, Wong D, McDonnell A, Folstein M: Neuropsychological and neuroradiological correlates in Huntington's disease. J Neurol Neurosurg Psychiatry 1988;51:1259-1263.
30. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG: A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:377-382.
31. StataCorp: Stata Statistical Software: Release 7.0. College Station, Stata Corporation, 2000
32. Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS: Progression of regional neuropathology in Alzheimer disease and normal elderly: Findings from the Nun study. Alzheimer Dis Assoc Disord 1999;13:226-231.
33. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO: Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1982;17: 37-49.